ScaleReady

ScaleReady is bringing the future of cell and gene therapies to life through the industry's most powerful and versatile manufacturing platform. ScaleReady enables rapid large-scale expansion of T cells while reducing complexity and cost. Established in 2020, ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf, combining each founding partner’s tools and technologies in cell culture, cell activation, gene editing, and cell processing.